Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T5SO
|
|||
| Drug Name |
Piperidine derivative 6
|
|||
| Synonyms |
PMID28051882-Compound-XII
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Merk Patent GMBH
|
|||
| Structure |
 |
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Opioid receptor sigma 1 (OPRS1) | Target Info | Ligand | [1] |
| Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] | |
| Target's Patent Info | Opioid receptor sigma 1 (OPRS1) | Target's Patent Info | [1] | |
| Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] | ||
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Are sigma modulators an effective opportunity for cancer treatment A patent overview (1996-2016).Expert Opin Ther Pat. 2017 May;27(5):565-578. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.